Xolair 150 mg lyophilized powder for injection Images
Generic Name: omalizumab
This medication has been identified as Xolair 150 mg lyophilized powder for injection. It is supplied by Genentech, Inc.
Xolair is used in the treatment of Urticaria; Food Allergies; Asthma; Chronic Rhinosinusitis With Nasal Polyps; Nasal Polyps and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Xolair 150 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Xolair
- Generic Name
- omalizumab
- Strength
- 150 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0040
More about Xolair (omalizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (218)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
